Friday Harbor, WA, United States of America

Howard Robert Grahame Clarke

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Cmc Icos Biologics, Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Howard Robert Grahame Clarke. Retrieved from https://idiyas.com/inventor/howard-robert-grahame-clarke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Howard Robert Grahame Clarke: Innovator in Recombinant Protein Expression

Introduction

Howard Robert Grahame Clarke is a notable inventor based in Friday Harbor, WA (US). He has made significant contributions to the field of biotechnology, particularly in the area of recombinant protein expression. His innovative methods have the potential to enhance the efficiency of gene expression in various applications.

Latest Patents

Clarke holds a patent titled "Methods for improving recombinant protein expression." This patent provides materials and methods that allow for increased expression of a transfected gene of interest in a recombinant host cell. His work in this area is crucial for advancing biopharmaceutical production and research.

Career Highlights

Clarke is associated with CMC Icos Biologics, Inc., where he applies his expertise in biotechnology. His role at the company allows him to further develop and implement his innovative ideas in the field of protein expression.

Conclusion

Howard Robert Grahame Clarke is a distinguished inventor whose work in recombinant protein expression has the potential to impact the biotechnology industry significantly. His contributions are paving the way for advancements in biopharmaceuticals and genetic research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…